Actively Recruiting
Minimally Invasive Treatments of the Thyroid
Led by European Institute of Oncology · Updated on 2024-03-27
270
Participants Needed
1
Research Sites
690 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)
CONDITIONS
Official Title
Minimally Invasive Treatments of the Thyroid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients older than 18 years
- Diagnosis of papillary thyroid microcarcinoma confirmed by cytology and suitable for MITT
- Signed written informed consent by the patient and investigator before joining
- Ability to attend follow-up visits
You will not qualify if you...
- Tumors larger than 1 cm or other cytological types
- Refusal of MITT or unsuitability for MITT
- Unmanageable blood clotting disorders
- Psychiatric, addictive, or other disorders affecting ability to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
European Institute of Oncology
Milan, Italy
Actively Recruiting
Research Team
G
Giovanni Mauri
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here